top of page

TransHeps

We are the DILI company offering cutting edge laboratory services and advisory expertise for Drug-Induced Liver Injury (DILI) in clinical trials.

AdobeStock_718024539.jpeg
Element-orange_0,5x.png

The DILI company

AdobeStock_672736476.jpeg

About us

We aim to improve safety during drug therapy by focusing on patient-specific DILI, a rare but potentially life-threatening side effect. More

MetaHeps technology

Make MetaHeps assay a breakthrough tool for DILI causality assessment in clinical studies. We serve global pharma & biotech companies as well as CROs to support drug approvals. More

AdobeStock_644916098.jpeg
Monique(1).jpg

Products & Services:

1. iDILI causality assays (for clinical trials and pharmacovigilance)

2. Mechanistic in-vitro studies to investigate DILI

3. Expert Advisory Services around DILI 
More

Differentiation 🌟

MetaHeps DILI causality assessment in clinical studies is unrivaled! We are the only industrial service provider of the MetaHeps assay.

AdobeStock_729890269.jpeg

👩‍🔬
Our Team

Seasoned scientists with proven expertise in clinical and experimental hepatology, ensuring top-tier quality standards.

📣
Contact us

To revolutionize drug safety!

bottom of page